Potent adjuvant effect by anti-CD40 in collagen-induced arthritis.: Enhanced disease is accompanied by increased production of collagen type-II reactive IgG2a and IFN-γ

被引:28
作者
Tellander, AC [1 ]
Michaëlsson, E [1 ]
Brunmark, C [1 ]
Andersson, M [1 ]
机构
[1] Act Biotech Res AB, SE-22007 Lund, Sweden
关键词
adjuvant; arthritis; autoantibodies; CD40; disease development;
D O I
10.1006/jaut.2000.0374
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Collagen type II-induced arthritis (CIA) is an experimental model of rheumatoid arthritis, an autoimmune inflammatory disease of the peripheral joints in humans. CD40 interaction with its ligand CD154 (CD40L) has been shown to be an obligatory step in the initiation of autoimmune disease in several animal models. In this study we report on the effect of CD40 stimulation in CIA induced by immunization with type II collagen (CII) in CFA or IFA. We found that the administration of stimulatory anti-CD40 mAb resulted in earlier onset and more severe disease in IFA-CII-immunized mice. The mAb treatment resulted in markedly elevated titers of CII-specific IgG2a antibodies whereas CII-specific IgG1 titers were unaffected. Draining lymphnode cell cultures from mice treated with anti-CD40 exhibited significantly increased IFN-gamma production compared to cultures from control antibody-treated mice. In conclusion, our results indicate that the level of CD40 activation during the induction of an autoimmune response may determine the severity of the resulting disease. (C) 2000 Academic Press.
引用
收藏
页码:295 / 302
页数:8
相关论文
共 35 条
[1]   CD40 EXPRESSION BY HUMAN MONOCYTES - REGULATION BY CYTOKINES AND ACTIVATION OF MONOCYTES BY THE LIGAND FOR CD40 [J].
ALDERSON, MR ;
ARMITAGE, RJ ;
TOUGH, TW ;
STROCKBINE, L ;
FANSLOW, WC ;
SPRIGGS, MK .
JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 178 (02) :669-674
[2]   MOLECULAR AND BIOLOGICAL CHARACTERIZATION OF A MURINE LIGAND FOR CD40 [J].
ARMITAGE, RJ ;
FANSLOW, WC ;
STROCKBINE, L ;
SATO, TA ;
CLIFFORD, KN ;
MACDUFF, BM ;
ANDERSON, DM ;
GIMPEL, SD ;
DAVISSMITH, T ;
MALISZEWSKI, CR ;
CLARK, EA ;
SMITH, CA ;
GRABSTEIN, KH ;
COSMAN, D ;
SPRIGGS, MK .
NATURE, 1992, 357 (6373) :80-82
[3]  
Balasa B, 1997, J IMMUNOL, V159, P4620
[4]   Help for cytotoxic-T-cell responses is mediated by CD40 signalling [J].
Bennett, SRM ;
Carbone, FR ;
Karamalis, F ;
Flavell, RA ;
Miller, JFAP ;
Heath, WR .
NATURE, 1998, 393 (6684) :478-480
[5]   CD40 ligation counteracts Fas-induced apoptosis of human dendritic cells [J].
Bjorck, P ;
Banchereau, J ;
FloresRomo, L .
INTERNATIONAL IMMUNOLOGY, 1997, 9 (03) :365-372
[6]   Suppression of murine thyroiditis via blockade of the CD40-CD40L interaction [J].
Carayanniotis, G ;
Masters, SR ;
Noelle, RJ .
IMMUNOLOGY, 1997, 90 (03) :421-426
[7]   ACTIVATION OF HUMAN DENDRITIC CELLS THROUGH CD40 CROSS-LINKING [J].
CAUX, C ;
MASSACRIER, C ;
VANBERVLIET, B ;
DUBOIS, B ;
VANKOOTEN, C ;
DURAND, I ;
BANCHEREAU, J .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 180 (04) :1263-1272
[8]  
Clark LB, 1996, ADV IMMUNOL, V63, P43
[9]   Enhancement of T cell-independent immune responses in vivo by CD40 antibodies [J].
Dullforce, P ;
Sutton, DC ;
Heath, AW .
NATURE MEDICINE, 1998, 4 (01) :88-91
[10]   PREVENTION OF COLLAGEN-INDUCED ARTHRITIS WITH AN ANTIBODY TO GP39, THE LIGAND FOR CD40 [J].
DURIE, FH ;
FAVA, RA ;
FOY, TM ;
ARUFFO, A ;
LEDBETTER, JA ;
NOELLE, RJ .
SCIENCE, 1993, 261 (5126) :1328-1330